Literature DB >> 16309164

Increased levels of PPARbeta/delta and cyclin D1 in flat dysplastic ACF and adenomas in Apc(Min/+) mice.

Helle K Knutsen1, Hege B Olstørn, Jan Erik Paulsen, Trine Husøy, Ingeborg L Goverud, Else Marit Løberg, Karsten Kristiansen, Jan Alexander.   

Abstract

BACKGROUND: In Apc(Min/+) (Min; multiple intestinal neoplasia) mice two separate populations of aberrant crypt foci (ACF) develop in the colon after azoxymethane (AOM) exposure. ACF(Min), with a flat appearance, severe dysplasia and increased beta-catenin expression, are related to adenoma development, whereas classic ACF, with elevated structure, hyperplasia and normal beta-catenin level, are probably not.
MATERIALS AND METHODS: The expressions of peroxisome proliferator-activated receptors (PPARs) beta/delta, cyclin D1 and beta-catenin in ACF, adenoma and normal tissue from AOM-treated Apc(Min/+) mice and a familial adenomatous polyposis (FAP) patient colon tumour were assessed by immunohistochemistry and immunoblotting.
RESULTS: The flat ACF (ACF(Min)) displayed increased cytoplasmic levels of beta-catenin, and increased levels of cyclin D1 and PPARbeta/delta. In contrast, the expression in classic ACF resembled normal mucosa. Adenomas from Apc(Min/+) mice, as well as a FAP patient colon tumour, displayed increased nuclear and cytoplasmic levels of beta-catenin, and the same expression patterns of cyclin D1 and PPARbeta/delta as those found in flat ACF.
CONCLUSION: In addition to activation of the Wnt signalling pathway in both flat ACF and in adenomas in Apc(Min/+) mice, the increased expression of PPARbeta/delta in these lesions could be a target for pro-inflammatory signals important for growth and reduced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309164

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  15 in total

1.  Potentiation of colon cancer susceptibility in mice by colonic epithelial PPAR-δ/β overexpression.

Authors:  Xiangsheng Zuo; Min Xu; Jiang Yu; Yuanqing Wu; Micheline J Moussalli; Ganiraju C Manyam; Sun Il Lee; Shoudan Liang; Mihai Gagea; Jeffrey S Morris; Russell R Broaddus; Imad Shureiqi
Journal:  J Natl Cancer Inst       Date:  2014-03-28       Impact factor: 13.506

Review 2.  The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention.

Authors:  Jeffrey M Peters; Yatrik M Shah; Frank J Gonzalez
Journal:  Nat Rev Cancer       Date:  2012-02-09       Impact factor: 60.716

3.  PPARδ and PGE2 signaling pathways communicate and connect inflammation to colorectal cancer.

Authors:  Dingzhi Wang; Raymond N DuBois
Journal:  Inflamm Cell Signal       Date:  2014-10-19

4.  Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.

Authors:  Clemens Röhrl; Ulrike Kaindl; Inga Koneczny; Xenia Hudec; David M Baron; Jürgen S König; Brigitte Marian
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-11       Impact factor: 4.553

Review 5.  Wnt signalling and the control of cellular metabolism.

Authors:  Jaswinder K Sethi; Antonio Vidal-Puig
Journal:  Biochem J       Date:  2010-03-15       Impact factor: 3.857

Review 6.  Targeting peroxisome proliferator-activated receptor-β/δ in colon cancer: how to aim?

Authors:  Min Xu; Xiangsheng Zuo; Imad Shureiqi
Journal:  Biochem Pharmacol       Date:  2012-10-04       Impact factor: 5.858

Review 7.  Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease.

Authors:  Jeffrey M Peters; Holly E Hollingshead; Frank J Gonzalez
Journal:  Clin Sci (Lond)       Date:  2008-08       Impact factor: 6.124

8.  The secondary bile acid, deoxycholate accelerates intestinal adenoma-adenocarcinoma sequence in Apc (min/+) mice through enhancing Wnt signaling.

Authors:  Hailong Cao; Shenhui Luo; Mengque Xu; Yujie Zhang; Shuli Song; Shan Wang; Xinyue Kong; Nana He; Xiaocang Cao; Fang Yan; Bangmao Wang
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

Review 9.  Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer.

Authors:  Jeffrey M Peters; Frank J Gonzalez
Journal:  Biochim Biophys Acta       Date:  2009-06-06

10.  Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs.

Authors:  Jennifer E Foreman; Joseph M Sorg; Kathleen S McGinnis; Basil Rigas; Jennie L Williams; Margie L Clapper; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Carcinog       Date:  2009-10       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.